Literature DB >> 25083197

Who should support the costs of severe adverse drug reactions?

Jean-Claude Roujeau1, Sophie Le Pallec2.   

Abstract

Year:  2011        PMID： 25083197      PMCID： PMC4110801          DOI： 10.1177/2042098610396118

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN： 2042-0986


× No keyword cloud information.
  9 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

Authors:  B Rzany; M Mockenhaupt; S Baur; W Schröder; U Stocker; J Mueller; N Holländer; R Bruppacher; E Schöpf
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

3.  Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.

Authors:  Jürgen Schneck; Jean-Paul Fagot; Peggy Sekula; Bruno Sassolas; Jean Claude Roujeau; Maja Mockenhaupt
Journal:  J Am Acad Dermatol       Date:  2007-10-04       Impact factor: 11.527

4.  A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

Authors:  Christine Lonjou; Nicolas Borot; Peggy Sekula; Neil Ledger; Laure Thomas; Sima Halevy; Luigi Naldi; Jan-Nico Bouwes-Bavinck; Alexis Sidoroff; Claudia de Toma; Martin Schumacher; Jean-Claude Roujeau; Alain Hovnanian; Maja Mockenhaupt
Journal:  Pharmacogenet Genomics       Date:  2008-02       Impact factor: 2.089

5.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

6.  Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi.

Authors:  John E Gimnig; John R MacArthur; Maurice M'bang'ombe; Michael H Kramer; Nyson Chizani; Robert S Stern; Chris Mkandala; Robert D Newman; Richard W Steketee; Carl H Campbell
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

7.  Compensation for medical misadventure and drug injury in the New Zealand no-fault system: feeling the way.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

8.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Authors:  J C Roujeau; J P Kelly; L Naldi; B Rzany; R S Stern; T Anderson; A Auquier; S Bastuji-Garin; O Correia; F Locati
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

Authors:  Maja Mockenhaupt; Cecile Viboud; Ariane Dunant; Luigi Naldi; Sima Halevy; Jan Nico Bouwes Bavinck; Alexis Sidoroff; Jürgen Schneck; Jean-Claude Roujeau; Antoine Flahault
Journal:  J Invest Dermatol       Date:  2007-09-06       Impact factor: 8.551
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.